MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-22-2025
IQVIA Holdings Operating Cycle 2011-2025 | IQV
Annual Operating Cycle IQVIA Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78 | 76.7 | 69.2 | 65.3 | 80.2 | 86.8 | 86.3 | 76.5 | 92.4 | 76.3 | 68.2 | 67.3 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.4 | 65.3 | 76.9 |
Quarterly Operating Cycle IQVIA Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.1 | 77.1 | - | 75.5 | 79.9 | 83.1 | - | 77.7 | 75.9 | 74.7 | - | 33.8 | 33.8 | 66.1 | - | 62 | 61.5 | 63.9 | 66.7 | 78.9 | 87.2 | 82.7 | 81.4 | 85.1 | 86 | 84.6 | 81.3 | 84.2 | 85.1 | 80 | 75.9 | 77.6 | 80.6 | 74.7 | - | 104 | 100 | 88 | - | 74.7 | 73.7 | 72.5 | - | 63.6 | 66.4 | 66.3 | - | 70.5 | 65.1 | 62 | - | 56.7 | 55.3 | 29.4 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 | 29.4 | 72.9 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DarioHealth Corp.
DRIO
|
251 | $ 11.98 | 0.76 % | $ 340 M |  Israel |
 |
DexCom
DXCM
|
204 | $ 66.7 | -0.39 % | $ 25.7 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.71 | 6.1 % | $ 180 M |  China |
 |
Exact Sciences Corporation
EXAS
|
269 | $ 101.53 | 0.03 % | $ 18.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
329 | $ 1.59 | -1.91 % | $ 2.02 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 38.47 | -0.41 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
150 | $ 226.5 | 0.08 % | $ 166 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.81 | -1.22 % | $ 811 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 415.66 | 1.58 % | $ 30 B |  Schweiz |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
87.1 | $ 7.01 | -2.77 % | $ 635 M | USA |
 |
NeoGenomics
NEO
|
103 | $ 12.08 | 1.94 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 6.83 | -0.51 % | $ 1.48 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.96 | -2.92 % | $ 1.07 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.56 | -0.7 % | $ 114 K | USA |
 |
Co-Diagnostics
CODX
|
405 | $ 0.31 | -9.02 % | $ 9.1 M | USA |
 |
Pacific Biosciences of California
PACB
|
183 | $ 2.11 | -0.71 % | $ 535 M | USA |
 |
Quidel Corporation
QDEL
|
68.4 | $ 28.87 | 0.24 % | $ 1.22 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.56 | -0.23 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
49.1 | $ 104.86 | 2.73 % | $ 12.9 B | USA |
 |
Precipio
PRPO
|
49.8 | $ 24.68 | -1.14 % | $ 32 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | $ 45.24 | 0.04 % | $ 10.1 B | Niderland |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
83.5 | $ 16.81 | -0.15 % | $ 4.75 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
193 | $ 51.43 | -1.1 % | $ 2.07 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
198 | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 196.55 | 1.82 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Thermo Fisher Scientific
TMO
|
69.8 | $ 567.34 | -0.76 % | $ 217 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 1.08 | 0.93 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 31.12 | 0.61 % | $ 1.86 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 183.54 | 0.54 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.76 | -1.15 % | $ 1.01 B | USA |